Gene,Ensembl,Gene description,Significant transcript(s),ARCHS4 (gene level),GTEx (gene level),TabulaSapiens (gene level),Total conditions (gene level),CellAge,SenMayo,AgedTissue,DiseaseTissue,Protein.class,Biological.process,Molecular.function,Disease.involvement,Evidence,RNA.tissue.specificity,RNA.tissue.distribution,RNA.tissue.specificity.score,RNA.tissue.specific.nTPM,RNA.single.cell.type.specificity,RNA.single.cell.type.distribution,RNA.single.cell.type.specificity.score,RNA.single.cell.type.specific.nTPM,RNA.cancer.specificity,RNA.cancer.distribution,RNA.cancer.specificity.score,RNA.cancer.specific.FPKM,RNA.brain.regional.specificity,RNA.brain.regional.distribution,RNA.brain.regional.specificity.score,RNA.brain.regional.specific.nTPM,RNA.blood.cell.specificity,RNA.blood.cell.distribution,RNA.blood.cell.specificity.score,RNA.blood.cell.specific.nTPM,RNA.blood.lineage.specificity,RNA.blood.lineage.distribution,RNA.blood.lineage.specificity.score,RNA.blood.lineage.specific.nTPM,RNA.cell.line.specificity,RNA.cell.line.distribution,RNA.cell.line.specificity.score,RNA.cell.line.specific.nTPM,RNA.tissue.cell.type.enrichment,RNA.mouse.brain.regional.specificity,RNA.mouse.brain.regional.distribution,RNA.mouse.brain.regional.specificity.score,RNA.mouse.brain.regional.specific.nTPM,RNA.pig.brain.regional.specificity,RNA.pig.brain.regional.distribution,RNA.pig.brain.regional.specificity.score,RNA.pig.brain.regional.specific.nTPM,Antibody,Reliability..IH.,Reliability..Mouse.Brain.,Reliability..IF.,Subcellular.location,Secretome.location,CCD.Protein,CCD.Transcript,Blood.concentration...Conc..blood.IM..pg.L.,Blood.concentration...Conc..blood.MS..pg.L.,Blood.expression.cluster,Tissue.expression.cluster,Cell.line.expression.cluster,Single.cell.expression.cluster,Subcellular.main.location,Subcellular.additional.location,Antibody.RRID
CHRM2,ENSG00000181072,Cholinergic receptor muscarinic 2,ENST00000401861; ENST00000445907,11,11,11,33,0,0,NA,NA,"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",FDA approved drug targets,Evidence at protein level,Tissue enhanced,Detected in some,NA,heart muscle: 36.1;intestine: 21.2,Group enriched,Detected in some,7,Cardiomyocytes: 72.6;Excitatory neurons: 48.4;Inhibitory neurons: 115.9,Cancer enhanced,Detected in single,NA,stomach cancer: 0.8,Low region specificity,Detected in many,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enriched,Detected in some,5,Neuroblastoma: 10.4,"Heart muscle - Cardiomyocytes, Liver - Hepatic stellate cells, Testis - Early spermatids, Testis - Late spermatids",Low region specificity,Detected in all,NA,,Low region specificity,Detected in many,NA,,"CAB022338, HPA029795",Approved,,,,,NA,NA,NA,NA,,Cluster 44: Heart - Cardiac muscle contraction,Cluster 20: Connective tissue cells - ECM organization,Cluster 37: Neurons - Neuronal signaling,,,"CAB022338: , HPA029795: AB_10601357"
PDCD1LG2,ENSG00000197646,Programmed cell death 1 ligand 2,ENST00000397747,12,11,9,32,1,0,Blood.Vessel,NA,"Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins","Adaptive immunity, Immunity",Receptor,Cancer-related genes,Evidence at protein level,Tissue enhanced,Detected in many,NA,lymphoid tissue: 15.1,Cell type enhanced,Detected in some,NA,Extravillous trophoblasts: 21.9;Fibroblasts: 7.3;granulocytes: 12.6;Langerhans cells: 14.1;Leydig cells: 6.9;Microglial cells: 11.9,Low cancer specificity,Detected in many,NA,,Low region specificity,Detected in some,NA,,Low immune cell specificity,Detected in some,NA,,Low lineage specificity,Detected in many,NA,,Low cancer specificity,Detected in many,NA,,"Breast - Fibroblasts, Kidney - Endothelial cells, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts",Not detected,Not detected,NA,,Low region specificity,Detected in all,NA,,HPA013411,Approved,,Uncertain,Cytosol,Secreted - unknown location,NA,NA,NA,3.10E+07,Cluster 46: Basophils - DNA binding,Cluster 16: Immune cells - Immune response,Cluster 20: Connective tissue cells - ECM organization,Cluster 23: Langerhans cells - Immune response,Cytosol,,HPA013411: AB_1855102
SCN9A,ENSG00000169432,Sodium voltage-gated channel alpha subunit 9,ENST00000303354; ENST00000409435; ENST00000409672; ENST00000454569,10,8,10,28,0,0,NA,NA,"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels","Ion transport, Sodium transport, Transport","Ion channel, Sodium channel, Voltage-gated channel","Disease variant, Epilepsy, FDA approved drug targets",Evidence at protein level,Tissue enriched,Detected in many,4,brain: 21.9,Cell type enhanced,Detected in many,NA,dendritic cells: 112.3;Hofbauer cells: 65.6;Langerhans cells: 53.8;Oligodendrocyte precursor cells: 128.0;Schwann cells: 90.9;Sertoli cells: 74.6,Low cancer specificity,Detected in some,NA,,Low region specificity,Detected in many,NA,,Immune cell enriched,Detected in some,16,plasmacytoid DC: 23.6,Lineage enriched,Detected in single,26,dendritic cells: 23.6,Cancer enhanced,Detected in many,NA,Rhabdoid: 44.9,"Kidney - Proximal tubular cells, Testis - Sertoli cells",Region enriched,Detected in many,5,hypothalamus: 9.3,Low region specificity,Detected in many,NA,,"CAB013679, HPA061843",Uncertain,,Approved,"Plasma membrane,Actin filaments,Focal adhesion sites",,NA,NA,NA,NA,Cluster 3: Plasmacytoid DCs - Unknown function,Cluster 73: Brain - Neuropeptide signaling,Cluster 22: Rhabdoid cancers - Neuronal signaling,Cluster 48: Plasmacytoid dendritic cells - Unknown function,"Plasma membrane, Actin filaments, Focal adhesion sites",,"CAB013679: , HPA061843: AB_2684625"
OXTR,ENSG00000180914,Oxytocin receptor,ENST00000316793; ENST00000431493,9,9,9,27,0,0,Blood.Vessel; Brain,NA,"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters",,"G-protein coupled receptor, Receptor, Transducer",FDA approved drug targets,Evidence at protein level,Group enriched,Detected in some,10,brain: 14.7;breast: 54.1,Cell type enriched,Detected in many,6,Breast myoepithelial cells: 160.7,Cancer enhanced,Detected in many,NA,ovarian cancer: 7.0,Low region specificity,Detected in all,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in all,NA,Bladder cancer: 30.6,Pancreas - Ductal cells,Low region specificity,Detected in many,NA,,Low region specificity,Detected in many,NA,,,,,,,,NA,NA,NA,NA,,Cluster 57: Non-specific - Angiogenesis,Cluster 20: Connective tissue cells - ECM organization,Cluster 38: Neurons - Neuronal signaling,,,
F2RL2,ENSG00000164220,Coagulation factor II thrombin receptor like 2,ENST00000296641,10,10,6,26,0,0,Blood.Vessel; Lung; Nerve,Idiopathic.Pulmonary.Fibrosis,"G-protein coupled receptors, Predicted membrane proteins","Blood coagulation, Hemostasis","G-protein coupled receptor, Receptor, Transducer",,Evidence at protein level,Tissue enhanced,Detected in many,NA,brain: 6.9;gallbladder: 6.8,Cell type enhanced,Detected in some,NA,Endometrial stromal cells: 2.3;Fibroblasts: 4.3;Rod photoreceptor cells: 4.7;Schwann cells: 7.5;Smooth muscle cells: 2.3,Cancer enhanced,Detected in many,NA,breast cancer: 9.8,Low region specificity,Detected in many,NA,,Immune cell enriched,Detected in some,9,basophil: 10.4,Lineage enriched,Detected in many,9,granulocytes: 10.4,Cancer enhanced,Detected in many,NA,Rhabdoid: 35.3,"Colon - Enteric glia cells, Heart muscle - Fibroblasts",Low region specificity,Detected in many,NA,,Low region specificity,Detected in all,NA,,,,,,,,NA,NA,NA,NA,Cluster 38: Basophils - Unknown function,Cluster 77: Retina - Visual perception,Cluster 61: Liver - Metabolism,Cluster 25: Schwann cells & Melanocytes - Mixed function,,,
THY1,ENSG00000154096,Thy-1 cell surface antigen,ENST00000524970,11,0,12,23,0,0,Blood.Vessel,Idiopathic.Pulmonary.Fibrosis; Heart.Failure,"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins",,,,Evidence at protein level,Tissue enhanced,Detected in many,NA,brain: 286.8;smooth muscle: 304.7;urinary bladder: 216.7,Cell type enhanced,Detected in many,NA,Endometrial stromal cells: 149.1;Excitatory neurons: 114.3;Fibroblasts: 173.9;Horizontal cells: 116.6;Inhibitory neurons: 101.6;Leydig cells: 99.8;Muller glia cells: 98.5;Proximal tubular cells: 162.8;Smooth muscle cells: 177.1,Low cancer specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in many,NA,Brain cancer: 436.6;thyroid cancer: 250.9,"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Liver - Hepatic stellate cells, Lung - Fibroblast_2, Skin - Fibroblast_1, Stomach - Fibroblasts, Thyroid - Fibroblasts",Low region specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,"HPA003733, CAB068243, CAB068244",Enhanced,,Approved,"Nucleoplasm,Plasma membrane",,NA,NA,NA,1.40E+07,Cluster 16: MAIT-cells - Unknown function,Cluster 10: Brain - Neuronal signaling,Cluster 20: Connective tissue cells - ECM organization,Cluster 65: Fibroblasts - ECM organization,Nucleoplasm,Plasma membrane,"CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340"
TRHDE,ENSG00000072657,Thyrotropin releasing hormone degrading enzyme,ENST00000261180; ENST00000547300; ENST00000549138; ENST00000549922,12,3,8,23,0,0,Lung,NA,"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins",,"Aminopeptidase, Hydrolase, Metalloprotease, Protease",,Evidence at protein level,Tissue enhanced,Detected in many,NA,brain: 7.6;pancreas: 10.3,Cell type enhanced,Detected in many,NA,Excitatory neurons: 213.3;Inhibitory neurons: 285.3;Late spermatids: 67.4,Cancer enhanced,Detected in some,NA,renal cancer: 1.9,Group enriched,Detected in many,5,basal ganglia: 4.9;cerebellum: 4.4;cerebral cortex: 2.5;hippocampal formation: 7.6,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in many,NA,Bone cancer: 6.5,"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Lung - Fibroblast_1, Prostate - Fibroblasts",Low region specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,,,,,,,NA,NA,NA,7300000,,Cluster 22: Non-specific - Unknown function,Cluster 10: Ovarian & Endometrial cancers - Unknown function,Cluster 37: Neurons - Neuronal signaling,,,
BDKRB1,ENSG00000100739,Bradykinin receptor B1,NA,9,8,5,22,0,0,NA,NA,"G-protein coupled receptors, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at protein level,Tissue enhanced,Detected in many,NA,urinary bladder: 23.4,Cell type enhanced,Detected in many,NA,Basal keratinocytes: 36.4;Basal squamous epithelial cells: 30.2;Squamous epithelial cells: 20.6;Suprabasal keratinocytes: 23.5;Thymic epithelial cells: 25.7,Low cancer specificity,Detected in many,NA,,Low region specificity,Detected in single,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in many,NA,cervical cancer: 18.6,"Kidney - Endothelial cells, Skin - Keratinocyte (other), Testis - Spermatocytes, Testis - Spermatogonia",Low region specificity,Detected in single,NA,,,,NA,,HPA002935,Approved,,,,,NA,NA,NA,NA,Cluster 4: T-regs - Cell cycle regulation,Cluster 11: Squamous epithelial cells - Epithelial cell function,Cluster 20: Connective tissue cells - ECM organization,Cluster 22: Squamous epithelial cells - Keratinization,,,HPA002935: AB_1078274
TRPA1,ENSG00000104321,Transient receptor potential cation channel subfamily A member 1,ENST00000262209; ENST00000520596; ENST00000522271; ENST00000523582,7,7,7,21,0,0,NA,NA,"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels","Ion transport, Sensory transduction, Transport",Ion channel,"Disease variant, FDA approved drug targets",Evidence at protein level,Tissue enhanced,Detected in some,NA,intestine: 9.2;stomach 1: 10.3;urinary bladder: 27.7,Cell type enhanced,Detected in some,NA,Early spermatids: 15.1;Excitatory neurons: 4.9;Fibroblasts: 6.1;Intestinal goblet cells: 32.2,Cancer enhanced,Detected in many,NA,breast cancer: 2.7,Not detected,Not detected,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in many,NA,Neuroblastoma: 6.6,"Testis - Early spermatids, Testis - Late spermatids",Not detected,Not detected,NA,,Low region specificity,Detected in some,NA,,,,,,,,NA,NA,NA,NA,Cluster 27: Non-specific - Gene expression,Cluster 37: Intestine - Unknown function,Cluster 20: Connective tissue cells - ECM organization,Cluster 26: Intestinal epithelial cells - Absorption,,,
PDGFRA,ENSG00000134853,Platelet derived growth factor receptor alpha,ENST00000509490,10,0,10,20,0,0,NA,NA,"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins","Chemotaxis, Host-virus interaction","Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase","Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene",Evidence at protein level,Tissue enhanced,Detected in all,NA,ovary: 190.2,Group enriched,Detected in many,7,Endometrial stromal cells: 374.7;Fibroblasts: 250.2;Leydig cells: 430.4;Oligodendrocyte precursor cells: 478.5;Peritubular cells: 384.7,Cancer enhanced,Detected in all,NA,glioma: 30.8,Low region specificity,Detected in all,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in many,NA,Rhabdoid: 76.7;thyroid cancer: 37.7,"Breast - Fibroblasts, Heart muscle - Fibroblasts, Kidney - Fibroblasts, Prostate - Fibroblasts",Low region specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,"HPA004947, CAB018143",Supported,,Approved,"Nucleoplasm,Plasma membrane,Cell Junctions",Intracellular and membrane,NA,NA,NA,3.00E+05,Cluster 34: Basophils - Unknown function,Cluster 89: Fibroblasts - ECM organization,Cluster 59: Fibroblasts - Metabolism,Cluster 52: Endometrial stromal cells - ECM organization,"Nucleoplasm, Plasma membrane, Cell Junctions",,"CAB018143: AB_2162351, HPA004947: AB_2732399"
ANO4,ENSG00000151572,Anoctamin 4,ENST00000392977,9,3,7,19,0,0,NA,NA,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Lipid transport, Transport",,,Evidence at protein level,Tissue enhanced,Detected in some,NA,adrenal gland: 12.0;brain: 11.3;cervix: 7.6;ovary: 7.7;seminal vesicle: 8.1,Group enriched,Detected in some,4,Inhibitory neurons: 524.3;Oligodendrocyte precursor cells: 265.2;Oligodendrocytes: 768.5,Cancer enhanced,Detected in some,NA,renal cancer: 2.1,Low region specificity,Detected in all,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in some,NA,skin cancer: 5.3;testis cancer: 7.6,,Low region specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,HPA053412,Uncertain,,,,,NA,NA,NA,NA,,Cluster 57: Non-specific - Angiogenesis,Cluster 20: Connective tissue cells - ECM organization,Cluster 37: Neurons - Neuronal signaling,,,HPA053412: AB_2682140
PCDH18,ENSG00000189184,Protocadherin 18,ENST00000510305,10,0,9,19,0,0,NA,NA,"Predicted intracellular proteins, Predicted membrane proteins",Cell adhesion,,,Evidence at protein level,Tissue enhanced,Detected in many,NA,placenta: 44.2,Cell type enhanced,Detected in many,NA,Endometrial stromal cells: 68.2;Fibroblasts: 53.1;Leydig cells: 39.2;Peritubular cells: 57.2;Smooth muscle cells: 30.7;Theca cells: 19.8,Low cancer specificity,Detected in many,NA,,Low region specificity,Detected in all,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in many,NA,Brain cancer: 24.6;testis cancer: 38.3,"Breast - Fibroblasts, Heart muscle - Fibroblasts, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Prostate - Fibroblasts, Thyroid - Fibroblasts",Low region specificity,Detected in many,NA,,Low region specificity,Detected in many,NA,,HPA017976,Approved,,Approved,"Golgi apparatus,Cytosol",,No,NA,NA,5900000,,Cluster 46: Fibroblasts - ECM organization,Cluster 20: Connective tissue cells - ECM organization,Cluster 52: Endometrial stromal cells - ECM organization,Cytosol,Golgi apparatus,HPA017976: AB_1855045
BDKRB2,ENSG00000168398,Bradykinin receptor B2,NA,10,0,8,18,0,0,Muscle,NA,"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters",,"G-protein coupled receptor, Receptor, Transducer",FDA approved drug targets,Evidence at protein level,Tissue enhanced,Detected in many,NA,urinary bladder: 41.1,Cell type enhanced,Detected in many,NA,Endometrial stromal cells: 16.3;Ionocytes: 16.5;Langerhans cells: 19.2;Squamous epithelial cells: 15.6,Low cancer specificity,Detected in many,NA,,Low region specificity,Detected in many,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Low cancer specificity,Detected in many,NA,,Kidney - Endothelial cells,Not detected,Not detected,NA,,Low region specificity,Detected in some,NA,,"HPA003551, HPA050841",Approved,,Supported,"Golgi apparatus,Vesicles,Plasma membrane",,NA,NA,NA,NA,,Cluster 12: Smooth muscle tissue - Mixed function,Cluster 20: Connective tissue cells - ECM organization,Cluster 66: Endothelial cells - Angiogenesis,Plasma membrane,"Golgi apparatus, Vesicles","HPA003551: , HPA050841: AB_2681254"
MYLK,ENSG00000065534,Myosin light chain kinase,ENST00000360304,6,0,11,17,1,0,NA,NA,"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins",,"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase","Aortic aneurysm, Disease variant",Evidence at protein level,Tissue enhanced,Detected in all,NA,seminal vesicle: 1700.3;smooth muscle: 2137.7,Cell type enhanced,Detected in many,NA,Breast myoepithelial cells: 917.4;Peritubular cells: 716.6;Sertoli cells: 223.9;Smooth muscle cells: 552.7,Low cancer specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,Immune cell enhanced,Detected in some,NA,basophil: 7.4,Low lineage specificity,Detected in many,NA,,Cancer enhanced,Detected in all,NA,Brain cancer: 98.7,"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Colon - Smooth muscle cells, Heart muscle - Smooth muscle cells, Kidney - Fibroblasts, Prostate - Smooth muscle cells, Skeletal muscle - Smooth muscle cells, Skin - Smooth muscle cells, Thyroid - Smooth muscle cells",Low region specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,"CAB020789, HPA031677, HPA048055",Enhanced,,Enhanced,"Plasma membrane,Actin filaments",,NA,NA,NA,1500000,Cluster 34: Basophils - Unknown function,Cluster 12: Smooth muscle tissue - Mixed function,Cluster 20: Connective tissue cells - ECM organization,Cluster 15: Smooth muscle cells - Muscle contraction,Actin filaments,Plasma membrane,"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"
CD248,ENSG00000174807,CD248 molecule,NA,9,0,7,16,0,0,NA,NA,"CD markers, Predicted membrane proteins",,,,Evidence at protein level,Tissue enhanced,Detected in many,NA,adipose tissue: 237.3;breast: 155.5,Group enriched,Detected in many,5,Endometrial stromal cells: 159.7;Fibroblasts: 187.7;Leydig cells: 76.7;Smooth muscle cells: 67.2;Thymic epithelial cells: 53.3,Low cancer specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,Immune cell enriched,Detected in some,7,naive CD8 T-cell: 21.8,Lineage enriched,Detected in single,144,T-cells: 21.8,Group enriched,Detected in many,6,Bone cancer: 145.3;Neuroblastoma: 37.3;Sarcoma: 72.9,"Breast - Adipocytes (Breast), Colon - Fibroblasts, Liver - Hepatic stellate cells, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Skin - Fibroblast_2, Stomach - Fibroblasts",Low region specificity,Detected in all,NA,,Low region specificity,Detected in many,NA,,HPA051856,Enhanced,,Approved,Plasma membrane,,NA,NA,NA,4.30E+07,Cluster 32: T-cells - Unknown function,Cluster 82: Adipose tissue - ECM organization,Cluster 20: Connective tissue cells - ECM organization,Cluster 65: Fibroblasts - ECM organization,Plasma membrane,,HPA051856: AB_2681640
CLDN1,ENSG00000163347,Claudin 1,NA,9,0,7,16,1,0,Blood.Vessel,NA,"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters",Host-virus interaction,"Host cell receptor for virus entry, Receptor",Ichthyosis,Evidence at protein level,Tissue enhanced,Detected in many,NA,liver: 309.8;skin 1: 288.2,Cell type enhanced,Detected in many,NA,Basal keratinocytes: 275.1;Basal prostatic cells: 242.9;Basal respiratory cells: 212.0;Basal squamous epithelial cells: 211.0;Ductal cells: 201.0;Salivary duct cells: 241.9;Squamous epithelial cells: 294.6;Suprabasal keratinocytes: 483.6,Low cancer specificity,Detected in all,NA,,Low region specificity,Detected in many,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Low cancer specificity,Detected in many,NA,,"Adipose visceral - Mesothelial cells, Pancreas - Ductal cells, Skin - Keratinocyte (other)",Low region specificity,Detected in many,NA,,Region enriched,Detected in some,12,spinal cord: 25.4,"CAB002602, HPA048319",Enhanced,,,,,NA,NA,NA,NA,,Cluster 85: Liver - Metabolism,Cluster 60: Keratinocytes - Epithelial cell function,Cluster 22: Squamous epithelial cells - Keratinization,,,"CAB002602: , HPA048319: AB_2680355"
ITGA11,ENSG00000137809,Integrin subunit alpha 11,NA,6,0,10,16,0,0,Blood.Vessel; Brain; Colon; Heart; Lung,NA,Predicted membrane proteins,Cell adhesion,"Integrin, Receptor",,Evidence at protein level,Tissue enhanced,Detected in many,NA,cervix: 26.3;endometrium 1: 53.1;smooth muscle: 25.0,Cell type enhanced,Detected in some,NA,Breast myoepithelial cells: 9.3;Cardiomyocytes: 12.6;Excitatory neurons: 13.1;Fibroblasts: 27.8;Horizontal cells: 14.7;Microglial cells: 18.2;Peritubular cells: 10.1;Smooth muscle cells: 10.6,Low cancer specificity,Detected in many,NA,,Low region specificity,Detected in some,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in many,NA,Bile duct cancer: 33.8,"Kidney - Fibroblasts, Thyroid - Fibroblasts",Not detected,Not detected,NA,,Group enriched,Detected in some,5,basal ganglia: 7.3;spinal cord: 2.1,HPA051813,Uncertain,,,,,NA,NA,NA,260000,,Cluster 89: Fibroblasts - ECM organization,Cluster 20: Connective tissue cells - ECM organization,Cluster 65: Fibroblasts - ECM organization,,,HPA051813: AB_2681622
LPAR1,ENSG00000198121,Lysophosphatidic acid receptor 1,ENST00000541779,7,0,8,15,0,0,NA,NA,"G-protein coupled receptors, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at protein level,Group enriched,Detected in many,4,brain: 358.4;choroid plexus: 122.2,Cell type enriched,Detected in many,4,Oligodendrocytes: 591.7,Low cancer specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,Group enriched,Detected in many,5,classical monocyte: 9.1;eosinophil: 19.0,Group enriched,Detected in many,6,granulocytes: 19.0;monocytes: 9.1,Low cancer specificity,Detected in many,NA,,"Breast - Fibroblasts, Colon - Enteric glia cells, Heart muscle - Fibroblasts",Low region specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,,,,,,,NA,NA,NA,NA,Cluster 45: Eosinophils - Innate immune response,Cluster 70: Brain - Nervous system development,Cluster 59: Fibroblasts - Metabolism,Cluster 8: Oligodendrocytes - Myelin sheath organization,,,
NT5E,ENSG00000135318,5'-nucleotidase ecto,ENST00000416334,6,0,9,15,0,0,Muscle,NA,"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins",,Hydrolase,Disease variant,Evidence at protein level,Tissue enhanced,Detected in many,NA,cervix: 112.6;retina: 94.4,Cell type enhanced,Detected in many,NA,Glandular and luminal cells: 63.2;Oligodendrocyte precursor cells: 58.7;Paneth cells: 57.7;Rod photoreceptor cells: 79.9,Low cancer specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,Immune cell enhanced,Detected in many,NA,naive B-cell: 33.0;naive CD8 T-cell: 30.7,Group enriched,Detected in many,41,B-cells: 33.0;T-cells: 30.7,Low cancer specificity,Detected in all,NA,,"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Breast - Fibroblasts, Heart muscle - Fibroblasts, Lung - Fibroblast_2, Skeletal muscle - Fibroblasts",Low region specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,HPA017357,Approved,,Supported,"Nucleoplasm,Plasma membrane,Cytosol",Intracellular and membrane,NA,NA,NA,3.00E+06,Cluster 21: B-cells - Adaptive immune response,Cluster 12: Smooth muscle tissue - Mixed function,Cluster 3: HUVEC & TIME - Signal transduction,Cluster 65: Fibroblasts - ECM organization,Plasma membrane,"Nucleoplasm, Cytosol",HPA017357: AB_1846330
SGCD,ENSG00000170624,Sarcoglycan delta,NA,9,0,6,15,0,0,NA,NA,"Disease related genes, Human disease related genes, Predicted membrane proteins",,,"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy",Evidence at protein level,Tissue enhanced,Detected in many,NA,heart muscle: 39.1;skeletal muscle: 42.9;tongue: 33.3,Cell type enhanced,Detected in many,NA,Astrocytes: 354.3;Cardiomyocytes: 142.1;Excitatory neurons: 190.3;Inhibitory neurons: 157.2;Microglial cells: 121.3;Oligodendrocyte precursor cells: 399.5;Oligodendrocytes: 185.4,Cancer enriched,Detected in many,5,melanoma: 10.1,Low region specificity,Detected in all,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in some,NA,skin cancer: 10.9,"Liver - Hepatic stellate cells, Pancreas - Fibroblasts, Prostate - Fibroblasts, Skin - Fibroblast_1",Low region specificity,Detected in many,NA,,Low region specificity,Detected in all,NA,,,,,,,,NA,NA,NA,NA,Cluster 32: T-cells - Unknown function,Cluster 38: Heart - Muscle contraction,Cluster 20: Connective tissue cells - ECM organization,Cluster 10: Neurons & Oligodendrocytes - Nervous system development,,,
TEK,ENSG00000120156,TEK receptor tyrosine kinase,ENST00000406359,9,0,6,15,0,0,NA,NA,"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins",Angiogenesis,"Kinase, Receptor, Transferase, Tyrosine-protein kinase","Cancer-related genes, Disease variant, FDA approved drug targets, Glaucoma",Evidence at protein level,Tissue enhanced,Detected in many,NA,placenta: 46.3,Group enriched,Detected in some,6,Adipocytes: 67.9;Endothelial cells: 76.7;Microglial cells: 37.4;Oligodendrocyte precursor cells: 131.9,Low cancer specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Group enriched,Detected in many,6,Rhabdoid: 16.9;testis cancer: 18.3,"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Sinusoid Endothelial cells, Lung - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells, Thyroid - Endothelial cells",Low region specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,"CAB010359, HPA073265",Approved,,Supported,"Plasma membrane,Centriolar satellite",Secreted to blood,NA,NA,7750000,1.30E+07,Cluster 9: Neutrophils - Innate immune response,Cluster 82: Adipose tissue - ECM organization,Cluster 3: HUVEC & TIME - Signal transduction,Cluster 66: Endothelial cells - Angiogenesis,Plasma membrane,Centriolar satellite,"CAB010359: AB_2203226, HPA073265: AB_2686592"
CNTNAP1,ENSG00000108797,Contactin associated protein 1,NA,5,0,9,14,0,0,NA,NA,"Disease related genes, Human disease related genes, Predicted membrane proteins",Cell adhesion,,"Disease variant, Neuropathy",Evidence at protein level,Tissue enhanced,Detected in many,NA,brain: 46.7,Cell type enhanced,Detected in many,NA,Bipolar cells: 23.2;Endometrial stromal cells: 17.8;Excitatory neurons: 44.9;Horizontal cells: 27.6;Inhibitory neurons: 36.8,Cancer enhanced,Detected in all,NA,glioma: 10.9,Low region specificity,Detected in all,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Low cancer specificity,Detected in all,NA,,"Adipose visceral - Adipose progenitor cells, Testis - Endothelial cells",Low region specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,HPA011772,Approved,,Approved,Nucleoplasm,,NA,NA,NA,NA,,Cluster 10: Brain - Neuronal signaling,Cluster 34: Rabdoid cancer - Embryonic development,Cluster 72: Smooth muscle cells - ECM organization,Nucleoplasm,,HPA011772: AB_1079541
CSPG4,ENSG00000173546,Chondroitin sulfate proteoglycan 4,NA,6,0,8,14,0,0,NA,NA,Predicted membrane proteins,"Angiogenesis, Differentiation, Tissue remodeling","Developmental protein, Transducer",,Evidence at protein level,Tissue enhanced,Detected in many,NA,intestine: 55.4,Group enriched,Detected in some,5,Melanocytes: 17.4;Oligodendrocyte precursor cells: 54.9;Schwann cells: 16.3;Sertoli cells: 55.3;Skeletal myocytes: 14.8;Smooth muscle cells: 49.3,Cancer enhanced,Detected in all,NA,melanoma: 74.9,Low region specificity,Detected in all,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in many,NA,skin cancer: 73.2,"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Colon - Smooth muscle cells, Lung - Smooth muscle cells, Prostate - Smooth muscle cells, Testis - Endothelial cells, Thyroid - Smooth muscle cells",Low region specificity,Detected in many,NA,,Low region specificity,Detected in all,NA,,"HPA001933, HPA002951, CAB016189, HPA042785, HPA050008",Approved,,Approved,Plasma membrane,,NA,NA,NA,4.80E+07,,Cluster 12: Smooth muscle tissue - Mixed function,Cluster 33: Skin cancer - Membrane components,Cluster 72: Smooth muscle cells - ECM organization,Plasma membrane,,"CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: AB_2680991"
CDH11,ENSG00000140937,Cadherin 11,NA,5,0,8,13,0,0,Blood.Vessel; Muscle,NA,"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins",Cell adhesion,,"Cancer-related genes, Deafness, Disease variant, Intellectual disability",Evidence at protein level,Tissue enhanced,Detected in many,NA,ovary: 178.2;placenta: 122.2,Cell type enhanced,Detected in many,NA,Astrocytes: 90.1;Endometrial stromal cells: 115.4;Excitatory neurons: 120.0;Microglial cells: 141.4;Oligodendrocyte precursor cells: 151.6;Oligodendrocytes: 100.4;Theca cells: 176.0,Low cancer specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in many,NA,Bone cancer: 104.9,"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Kidney - Fibroblasts, Lung - Fibroblast_1, Testis - Peritubular cells, Thyroid - Fibroblasts",Low region specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,CAB013072,Enhanced,,,,,NA,Yes,NA,4800000,,Cluster 89: Fibroblasts - ECM organization,Cluster 20: Connective tissue cells - ECM organization,Cluster 53: Connective tissue cells - ECM organization,,,CAB013072: AB_2533068
FAT1,ENSG00000083857,FAT atypical cadherin 1,ENST00000509647; ENST00000614102,0,0,12,12,1,0,NA,NA,"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins",Cell adhesion,,Cancer-related genes,Evidence at protein level,Tissue enhanced,Detected in many,NA,choroid plexus: 119.2,Cell type enhanced,Detected in many,NA,Basal respiratory cells: 113.3;Salivary duct cells: 99.1,Low cancer specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Low cancer specificity,Detected in all,NA,,Breast - Breast myoepithelial cells,Low region specificity,Detected in all,NA,,,,NA,,"HPA001869, HPA023882",Enhanced,,,,Intracellular and membrane,NA,NA,NA,4600000,,Cluster 88: Choroid plexus - Transmembrane transport,Cluster 20: Connective tissue cells - ECM organization,Cluster 5: Bronchus - Unknown function,,,"HPA001869: AB_1078818, HPA023882: AB_1848429"
GJD3,ENSG00000183153,Gap junction protein delta 3,NA,0,12,0,12,0,0,NA,NA,Predicted membrane proteins,,,,Evidence at protein level,Tissue enhanced,Detected in many,NA,lymphoid tissue: 8.1,Cell type enhanced,Detected in some,NA,Adipocytes: 4.1;Basal prostatic cells: 2.1;Endometrial stromal cells: 2.3;Endothelial cells: 3.8;Glandular and luminal cells: 1.5;Theca cells: 1.6,Cancer enhanced,Detected in single,NA,stomach cancer: 1.1,Not detected,Not detected,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Low cancer specificity,Detected in many,NA,,,Not detected,Not detected,NA,,,,NA,,,,,,,,NA,NA,NA,NA,,Cluster 64: Macrophages - Immune response,Cluster 36: Non-specific - Unknown function,Cluster 66: Endothelial cells - Angiogenesis,,,
HLA-G,ENSG00000204632,"Major histocompatibility complex, class I, G",NA,8,4,0,12,0,0,NA,NA,"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins",Immunity,,Cancer-related genes,Evidence at protein level,Group enriched,Detected in some,5,pituitary gland: 13.8;placenta: 11.1,Cell type enriched,Detected in many,21,Extravillous trophoblasts: 2193.5,Low cancer specificity,Detected in all,NA,,Not detected,Not detected,NA,,Low immune cell specificity,Detected in many,NA,,Low lineage specificity,Detected in many,NA,,Cancer enhanced,Detected in single,NA,lung cancer: 1.5,Testis - Late spermatids,,,NA,,,,NA,,CAB016158,Enhanced,,,,Secreted to blood,NA,NA,32800000,6.70E+07,Cluster 5: Granulocytes - Unknown function,Cluster 28: Placenta - Pregnancy,Cluster 46: Non-specific - Unknown function,Cluster 54: Extravillous trophoblasts - Unknown function,,,CAB016158: AB_627938
ACKR4,ENSG00000129048,Atypical chemokine receptor 4,ENST00000249887,5,3,3,11,0,0,NA,NA,"G-protein coupled receptors, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at protein level,Tissue enhanced,Detected in many,NA,intestine: 15.8,Cell type enhanced,Detected in many,NA,Alveolar cells type 1: 17.2;Exocrine glandular cells: 10.5;Fibroblasts: 18.0;Proximal enterocytes: 20.3;Respiratory ciliated cells: 24.8,Cancer enhanced,Detected in many,NA,stomach cancer: 2.5,Not detected,Not detected,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in some,NA,lymphoma: 4.7,Thyroid - Fibroblasts,Group enriched,Detected in some,7,cerebellum: 4.7;pons and medulla: 1.5,Low region specificity,Detected in all,NA,,HPA054926,,,Approved,"Vesicles,Mitochondria",,NA,NA,NA,NA,Cluster 41: Basophils - Cellular respiration,Cluster 31: Skin - Epidermis development,Cluster 20: Connective tissue cells - ECM organization,Cluster 65: Fibroblasts - ECM organization,"Vesicles, Mitochondria",,HPA054926: 
CDH2,ENSG00000170558,Cadherin 2,NA,3,0,8,11,0,0,Blood.Vessel; Nerve,Idiopathic.Pulmonary.Fibrosis,"CD markers, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins",Cell adhesion,,"Cardiomyopathy, Disease variant, Intellectual disability",Evidence at protein level,Tissue enhanced,Detected in many,NA,heart muscle: 196.0,Cell type enhanced,Detected in many,NA,Astrocytes: 211.0;Cardiomyocytes: 387.3;Excitatory neurons: 306.3;Granulosa cells: 302.3;Inhibitory neurons: 193.1;Oligodendrocyte precursor cells: 256.6,Cancer enhanced,Detected in all,NA,glioma: 39.3,Low region specificity,Detected in all,NA,,Group enriched,Detected in some,5,basophil: 1.7;neutrophil: 1.3,Lineage enriched,Detected in single,6,granulocytes: 1.7,Low cancer specificity,Detected in all,NA,,Colon - Enteric glia cells,Low region specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,"CAB000141, CAB018580, HPA058574, CAB078686, CAB080169",Enhanced,,Supported,"Plasma membrane,Cell Junctions",,NA,NA,NA,1.60E+08,Cluster 10: Basophils - Unknown function,Cluster 44: Heart - Cardiac muscle contraction,Cluster 68: Kidney - Mixed function,Cluster 17: Granulosa cells - Transcription regulation,Plasma membrane,Cell Junctions,"CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, CAB080169: , HPA058574: AB_2683760"
CHRNA1,ENSG00000138435,Cholinergic receptor nicotinic alpha 1 subunit,NA,4,7,0,11,0,0,NA,NA,"Disease related genes, Human disease related genes, Predicted membrane proteins, Transporters","Ion transport, Transport","Ion channel, Ligand-gated ion channel, Receptor","Congenital myasthenic syndrome, Disease variant",Evidence at protein level,Tissue enriched,Detected in some,8,skeletal muscle: 170.1,Cell type enriched,Detected in some,13,Skeletal myocytes: 152.4,Cancer enhanced,Detected in many,NA,glioma: 5.8,Group enriched,Detected in some,13,cerebral cortex: 12.8;hippocampal formation: 5.5,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enriched,Detected in some,39,Sarcoma: 113.1,"Testis - Early spermatids, Testis - Late spermatids",Not detected,Not detected,NA,,Low region specificity,Detected in many,NA,,HPA071554,Enhanced,,Supported,Plasma membrane,,NA,NA,NA,NA,Cluster 47: Plasmacytoid DCs - Protein folding,Cluster 33: Striated muscle - Muscle contraction,Cluster 42: Sarcoma - Muscle contraction,Cluster 11: Non-specific - Transcription,Plasma membrane,,HPA071554: AB_2686416
FZD2,ENSG00000180340,Frizzled class receptor 2,NA,5,6,0,11,0,0,NA,NA,"Cancer-related genes, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins",Wnt signaling pathway,"Developmental protein, G-protein coupled receptor, Receptor, Transducer","Cancer-related genes, Disease variant",Evidence at protein level,Tissue enhanced,Detected in many,NA,choroid plexus: 10.5,Cell type enhanced,Detected in many,NA,Alveolar cells type 1: 20.2;Leydig cells: 41.6;Peritubular cells: 36.1,Low cancer specificity,Detected in all,NA,,Low region specificity,Detected in many,NA,,Immune cell enhanced,Detected in some,NA,classical monocyte: 1.1;myeloid DC: 1.8,Group enriched,Detected in many,7,dendritic cells: 1.8;monocytes: 1.1,Low cancer specificity,Detected in all,NA,,Thyroid - Fibroblasts,Low region specificity,Detected in many,NA,,Low region specificity,Detected in many,NA,,HPA057667,Uncertain,,Approved,"Nucleoplasm,Nuclear bodies,Cell Junctions",,NA,NA,NA,NA,Cluster 28: Myeloid DCs - Unknown function,Cluster 42: Ciliated cells - Cilium & Cell projection,Cluster 20: Connective tissue cells - ECM organization,Cluster 53: Connective tissue cells - ECM organization,"Nucleoplasm, Nuclear bodies",Cell Junctions,HPA057667: AB_2683497
IL12A,ENSG00000168811,Interleukin 12A,NA,5,5,1,11,0,0,NA,NA,"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins",Host-virus interaction,"Cytokine, Growth factor",Cancer-related genes,Evidence at protein level,Tissue enhanced,Detected in some,NA,esophagus: 4.1,Cell type enhanced,Detected in some,NA,Endometrial ciliated cells: 3.6;Oligodendrocyte precursor cells: 3.9;Plasma cells: 3.3;Respiratory ciliated cells: 2.9;Schwann cells: 4.0,Low cancer specificity,Detected in some,NA,,Low region specificity,Detected in many,NA,,Immune cell enhanced,Detected in single,NA,naive B-cell: 2.2,Low lineage specificity,Detected in single,NA,,Low cancer specificity,Detected in many,NA,,,Region enhanced,Detected in single,NA,cerebral cortex: 2.8,Not detected,Not detected,NA,,HPA001886,Uncertain,,,,Secreted to blood,NA,NA,NA,NA,Cluster 19: B-cells - Humoral immune response,Cluster 27: Brain & Skin - Unknown function,Cluster 20: Connective tissue cells - ECM organization,Cluster 32: Neurons - Synaptic function,,,HPA001886: AB_1079132
MRGPRF,ENSG00000172935,MAS related GPR family member F,NA,11,0,0,11,0,0,NA,NA,"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at protein level,Tissue enhanced,Detected in many,NA,endometrium 1: 171.2;intestine: 159.2,Cell type enhanced,Detected in many,NA,Fibroblasts: 29.1;Leydig cells: 67.4;Peritubular cells: 99.4;Smooth muscle cells: 78.2;Thymic epithelial cells: 31.7,Low cancer specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in many,NA,Brain cancer: 6.0;Sarcoma: 6.0,"Breast - Smooth muscle cells, Colon - Smooth muscle cells, Prostate - Smooth muscle cells, Thyroid - Smooth muscle cells",Region enriched,Detected in many,5,cerebellum: 14.8,Region enhanced,Detected in some,NA,spinal cord: 4.8,HPA028811,Approved,,Supported,"Nuclear membrane,Plasma membrane",,NA,NA,NA,NA,,Cluster 12: Smooth muscle tissue - Mixed function,Cluster 20: Connective tissue cells - ECM organization,Cluster 72: Smooth muscle cells - ECM organization,"Nuclear membrane, Plasma membrane",,HPA028811: AB_10603875
NTM,ENSG00000182667,Neurotrimin,ENST00000425719,6,0,5,11,0,0,Colon; Nerve,NA,"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins",Cell adhesion,,,Evidence at protein level,Tissue enhanced,Detected in many,NA,brain: 321.8;choroid plexus: 89.2;retina: 74.8,Cell type enhanced,Detected in many,NA,Astrocytes: 2096.8;Cone photoreceptor cells: 486.0;Excitatory neurons: 641.6;Inhibitory neurons: 1032.5;Oligodendrocyte precursor cells: 1848.9;Oligodendrocytes: 1187.2;Rod photoreceptor cells: 1314.5,Low cancer specificity,Detected in many,NA,,Low region specificity,Detected in all,NA,,Immune cell enriched,Detected in single,175,plasmacytoid DC: 17.4,Lineage enriched,Detected in single,175,dendritic cells: 17.4,Group enriched,Detected in many,6,Bone cancer: 26.0;Brain cancer: 19.5;Kidney cancer: 9.4;Sarcoma: 17.3;skin cancer: 21.2;thyroid cancer: 21.1,"Colon - Enteric glia cells, Skeletal muscle - Fibroblasts, Stomach - Fibroblasts, Thyroid - Fibroblasts",Low region specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,CAB024875,Enhanced,,,,Intracellular and membrane,NA,NA,NA,5.80E+07,Cluster 47: Plasmacytoid DCs - Protein folding,Cluster 65: Brain - Ion transport,Cluster 33: Skin cancer - Membrane components,Cluster 10: Neurons & Oligodendrocytes - Nervous system development,,,CAB024875: 
PSG9,ENSG00000183668,Pregnancy specific beta-1-glycoprotein 9,ENST00000621109,0,11,0,11,1,0,NA,NA,"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins",,,,Evidence at protein level,Tissue enriched,Detected in single,135,placenta: 106.3,Cell type enriched,Detected in some,25,Syncytiotrophoblasts: 222.5,Not detected,Not detected,NA,,Not detected,Not detected,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in many,NA,breast cancer: 27.5;Rhabdoid: 25.3,,,,NA,,,,NA,,HPA046327,Supported,,,,Secreted in female reproductive system,NA,NA,NA,4.30E+07,,Cluster 28: Placenta - Pregnancy,Cluster 20: Connective tissue cells - ECM organization,Cluster 67: Syncytiotrophoblasts - Pregnancy,,,HPA046327: AB_2679624
SEMA5A,ENSG00000112902,Semaphorin 5A,NA,1,0,10,11,0,0,NA,NA,"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins","Differentiation, Neurogenesis",Developmental protein,,Evidence at protein level,Tissue enhanced,Detected in many,NA,brain: 35.4,Cell type enriched,Detected in many,7,Oligodendrocyte precursor cells: 1139.4,Low cancer specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,Immune cell enriched,Detected in single,12,plasmacytoid DC: 2.9,Lineage enriched,Detected in single,12,dendritic cells: 2.9,Low cancer specificity,Detected in many,NA,,"Kidney - Podocytes, Skeletal muscle - Fibroblasts, Thyroid - Fibroblasts",Low region specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,HPA004632,Approved,,,,,NA,NA,NA,13000,Cluster 47: Plasmacytoid DCs - Protein folding,Cluster 10: Brain - Neuronal signaling,Cluster 20: Connective tissue cells - ECM organization,Cluster 10: Neurons & Oligodendrocytes - Nervous system development,,,HPA004632: AB_1079905
GPC1,ENSG00000063660,Glypican 1,ENST00000455111,0,0,10,10,1,0,NA,NA,"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins",,,,Evidence at protein level,Tissue enhanced,Detected in many,NA,skin 1: 226.0,Cell type enhanced,Detected in many,NA,Extravillous trophoblasts: 222.4,Low cancer specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Cancer enhanced,Detected in all,NA,Gallbladder cancer: 372.1,"Colon - Enteric glia cells, Skin - Keratinocyte (other), Testis - Sertoli cells",Low region specificity,Detected in all,NA,,Low region specificity,Detected in all,NA,,"HPA030571, HPA070449",Enhanced,,Supported,"Plasma membrane,Cytosol",Intracellular and membrane,NA,NA,NA,9500000,,Cluster 31: Skin - Epidermis development,Cluster 20: Connective tissue cells - ECM organization,Cluster 54: Extravillous trophoblasts - Unknown function,"Plasma membrane, Cytosol",,"HPA030571: AB_10602322, HPA070449: "
TMEM262,ENSG00000187066,Transmembrane protein 262,NA,0,10,0,10,0,0,NA,NA,Predicted membrane proteins,,,,Evidence at protein level,Tissue enriched,Detected in single,43,testis: 21.1,Cell type enriched,Detected in some,11,Early spermatids: 214.7,Not detected,Not detected,NA,,Not detected,Not detected,NA,,Not detected in immune cells,Not detected,NA,,Not detected,Not detected,NA,,Not detected,Not detected,NA,,"Testis - Early spermatids, Testis - Late spermatids",Not detected,Not detected,NA,,Not detected,Not detected,NA,,,,,,,,NA,NA,NA,NA,Cluster 1: Neutrophils - Mixed function,Cluster 74: Testis - Spermatogenesis,Cluster 52: Spermatids - Smell perception,Cluster 57: Early spermatids - Flagellum & Golgi organization,,,